A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints

被引:18
作者
Zvi, A [1 ]
Tugarinov, V [1 ]
Faiman, GA [1 ]
Horovitz, A [1 ]
Anglister, J [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2000年 / 267卷 / 03期
关键词
deuteration; double-mutant cycles; neutralizing antibody; NMR; V3; peptide;
D O I
10.1046/j.1432-1327.2000.01055.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 0.5 beta monoclonal antibody is a very potent strain-specific HIV-neutralizing antibody raised against gp120, the envelope glycoprotein of HIV-1. This antibody recognizes the V3 loop of gp120, which is a major neutralizing determinant of the virus. The antibody-peptide interactions, involving aromatic and negatively charged residues of the antibody 0.5 beta, were studied by NMR and double-mutant cycles. A deuterated V3 peptide and a Fab containing deuterated aromatic amino acids were used to assign these interactions to specific V3 residues and to the amino acid type and specific chain of the antibody by NOE difference spectroscopy, Electrostatic interactions between negatively charged residues of the antibody Fv and peptide residues were studied by mutagenesis of both antibody and peptide residues and double-mutant cycles. Several interactions could be assigned unambiguously: F96(L) of the antibody interacts with Pro13 of the peptide, H52(H) interacts with Ile7, Ile9 and Gln10 and D56(H) interacts with Arg11. The interactions of the light-chain tyrosines with Pro13 and Gly14 could be assigned to either Y30a(L) and Y32(L), respectively, or Y32(L) and Y49(L), respectively. Three heavy-chain tyrosines interact with Ile7, Ile20 and Phe17. Several combinations of assignments involving Y32(H), Y53(H), Y96(H) and Y100a(H) may satisfy the NMR and mutagenesis constraints, and therefore at this stage the interactions of the heavy-chain tyrosines were not taken into account. The unambiguous assignments [F96(L), H52(H) and D56(H)] and the two possible assignments of the light-chain tyrosines were used to dock the peptide into the antibody-combining site. The peptide converges to a unique position within the binding site, with the RCPG loop pointing into the center of the groove formed by the antibody complementary determining regions while retaining the beta-hairpin conformation and the type-VI RGPG turn [Tugarinov, V, Zvi, A., Levy, R. & Anglister, J. (1999) Nat. Struct. Biol. 6, 331-335].
引用
收藏
页码:767 / 779
页数:13
相关论文
共 43 条
[1]   Standard conformations for the canonical structures of immunoglobulins [J].
AlLazikani, B ;
Lesk, AM ;
Chothia, C .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (04) :927-948
[2]   MLEV-17-BASED TWO-DIMENSIONAL HOMONUCLEAR MAGNETIZATION TRANSFER SPECTROSCOPY [J].
BAX, A ;
DAVIS, DG .
JOURNAL OF MAGNETIC RESONANCE, 1985, 65 (02) :355-360
[3]   ISOTOPE-FILTERED 2D HOHAHA SPECTROSCOPY OF A PEPTIDE-PROTEIN COMPLEX USING HETERONUCLEAR HARTMANN-HAHN DEPHASING [J].
BAX, A ;
GRZESIEK, S ;
GRONENBORN, AM ;
CLORE, GM .
JOURNAL OF MAGNETIC RESONANCE SERIES A, 1994, 106 (02) :269-273
[4]  
Brunger AT, 1992, X PLOR 3 1 MANUAL
[5]   DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS [J].
CALLAHAN, LN ;
PHELAN, M ;
MALLINSON, M ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1543-1550
[6]   Contribution of arginine residues in the RP135 peptide derived from the V3 loop of gp120 to its interaction with the Fv fragment of the 0.5 beta HIV-1 neutralizing antibody [J].
Faiman, GA ;
Levy, R ;
Anglister, J ;
Horovitz, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) :13829-13833
[7]   CRYSTAL-STRUCTURE OF THE PRINCIPAL NEUTRALIZATION SITE OF HIV-1 [J].
GHIARA, JB ;
STURA, EA ;
STANFIELD, RL ;
PROFY, AT ;
WILSON, IA .
SCIENCE, 1994, 264 (5155) :82-85
[8]   CALCULATION OF PROTEIN EXTINCTION COEFFICIENTS FROM AMINO-ACID SEQUENCE DATA [J].
GILL, SC ;
VONHIPPEL, PH .
ANALYTICAL BIOCHEMISTRY, 1989, 182 (02) :319-326
[9]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEUTRALIZATION EPITOPE WITH CONSERVED ARCHITECTURE ELICITS EARLY TYPE-SPECIFIC ANTIBODIES IN EXPERIMENTALLY INFECTED CHIMPANZEES [J].
GOUDSMIT, J ;
DEBOUCK, C ;
MELOEN, RH ;
SMIT, L ;
BAKKER, M ;
ASHER, DM ;
WOLFF, AV ;
GIBBS, CJ ;
GAJDUSEK, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4478-4482
[10]   A MACROMOLECULAR MULTICOMPONENT PEPTIDE VACCINE PREPARED USING THE GLUTARALDEHYDE CONJUGATION METHOD WITH STRONG IMMUNOGENICITY FOR HIV-1 [J].
HAMAJIMA, K ;
BUKAWA, H ;
FUKUSHIMA, J ;
KAWAMOTO, S ;
KANEKO, T ;
SEKIGAWA, KI ;
TANAKA, SI ;
TSUKUDA, M ;
OKUDA, K .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 77 (03) :374-379